- Global Pharma News & Resources

Press Releases - 2023-03-31

Date Title Company
31-Mar-2023 Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia Rxilient Biotech
31-Mar-2023 PAION AG implements resolved capital reduction PAION AG
31-Mar-2023 TOPTICA is growing TOPTICA
31-Mar-2023 The Brains Marketing Group Launches Rocket Healthcare Marketing, A Powerful & Affordable Healthcare Marketing Platform The Brains Marketing Group
31-Mar-2023 MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023 MediClin AG
31-Mar-2023 Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis Almirall
31-Mar-2023 HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer HUTCHMED
31-Mar-2023 BioSenic provides financial update and financial calendar 2023 BioSenic
31-Mar-2023 Call for urgency to deliver on global pledge for antibiotic incentives ABPI
31-Mar-2023 Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus Sartorius Stedim Biotech SA
31-Mar-2023 Lonza Launches Share Buyback Program of up to CHF 2 Billion Lonza Group AG
31-Mar-2023 AEVIS VICTORIA SA – Publication of the Annual Report 2022 AEVIS VICTORIA SA
31-Mar-2023 Modern Dental Group Announces 2022 Annual Results - Recorded the Second Highest Net Profit of HK$221 million and Built a Comprehensive Dental Ecosystem with High-quality Development Modern Dental Group Limited
30-Mar-2023 BioSenic publishes new data on the mechanism of action of arsenic trioxide (ATO) BioSenic
30-Mar-2023 Molecure Announces Full Year Financial 2022 Results – A Year of Significant Progress Molecure S.A.